1 |
Yun, S. H., Lee, W. G., Kim, Y. C., Ju, E. S., Lim, B. K., Choi, J. O., Kim, D. K. and Jeon, E. S. (2012) Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis. J. Infect. Dis. 205: 491-497.
DOI
ScienceOn
|
2 |
Ramsingh, A. I., Lee, W. T., Collins, D. N. and Armstrong, L. E. (1997) Differential recruitment of B and T cells in coxsackievirus B4-induced pancreatitis is influenced by a capsid protein. J. Virol. 71: 8690-8697.
|
3 |
Ramsingh, A. I. (2008) CVB-induced pancreatitis and alterations in gene expression. Curr. Top Microbiol Immunol. 323: 241-258.
|
4 |
Ramsingh, A. I., Lee, W. T., Collins, D. N. and Armstrong, L. E. (1999) T cells contribute to disease severity during coxsackievirus B4 infection. J. Virol. 73: 3080-3086.
|
5 |
Caggana, M., Chan, P. and Ramsingh, A. (1993) Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67: 4797-4803.
|
6 |
Stevens, T., Conwell, D. L. and Zuccaro, G. (2004) Pathogenesis of chronic pancreatitis: an evidence-based review of past theories and recent developments. Am J. Gastroenterol. 99: 2256-2270.
DOI
|
7 |
Lee, C. H., Kim, J. H., Lee, H. J., Lee, S. M. and Kho, Y. H. (2001) Two new constituents of Isodon excisus and their evaluation in an apoptosis inhibition assay. J. Nat. Prod. 64: 659-660.
DOI
ScienceOn
|
8 |
Lim, B. K. and Kim, J. H. (2014) ORI2 inhibits coxsackievirus replication and myocardial inflammation in experimental murine myocarditis. Bio. Pharm. Bull. 37: 1650-1654.
DOI
|
9 |
Lim, B. K., Choi, J. H., Nam, J. H., Gil, C. O., Shin, J. O., Yun, S. H., Kim, D. K. and Jeon, E. S. (2006) Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Cardiovasc. Res. 71: 517-526.
DOI
ScienceOn
|
10 |
Lim, B. K., Choe, S. C., Shin, J. O., Ho, S. H., Kim, J. M., Yu, S. S., Kim, S. and Jeon, E. S. (2002) Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis. Circulation 105: 1278-1281.
|
11 |
Huber, S. A. and Lodge, P. A. (1986) Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am. J. Pathol. 122: 284-291.
|
12 |
Racaniello, V. R. Chapter24, The picornaviridae; The Viruses and Their Replication. Fields Virology (2007).
|
13 |
Tan, E. L., Wong, A. P. and Poh, C. L. (2010) Development of potential antiviral strategy against coxsackievirus B4. Virus Res. 150: 85-92.
DOI
|
14 |
Wang, S. M. and Liu, C. C. (2014) Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine. Expert. Rev. Anti. Infect. Ther. 12: 447-456.
DOI
|
15 |
Pinkert, S., Westermann, D., Wang, X., Klingel, K., Dorner A., Savvatis, K., Grossl, T., Krohn, S., Tschope, C., Zeichhardt, H., Kotsch, K., Weitmann, K., Hoffmann, W., Schultheiss, H. P., Spiller, O. B., Poller, W. and Fechner, H. (2009) Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus- adenovirus receptor. Circulation 120: 2358-2366.
DOI
|
16 |
Jaidane, H. and Hober, D. (2008) Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab. 34: 537-548.
DOI
|
17 |
Potvin, D. M., Metzger, D. W., Lee, W. T., Collins, D. N. and Ramsingh, A. I. (2003) Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4. J. Virol. 77: 8272-8279.
DOI
|
18 |
De Palma, A. M., Thibaut, H. J., Li S., Van, Aelst I., Dillen, C., Swinnen, M., Verbeken, E., Neyts, J. and Opdenakker, G. (2009) Inflammatory rather than infectious insults play a role in exocrine tissue damage in a mouse model for coxsackievirus B4-induced pancreatitis. J. Pathol. 217: 633-641.
DOI
|